SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON

Company

JOHNSON & JOHNSON

Filed

January 22, 2019

Accession Number

0000904454-19-000079

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →